JUN 15, 2015 11:52 AM PDT

Spicy Solution to Curb Colorectal Cancer

The best way to keep an aggressive disease at bay may be on your spice rack, not in your medicine cabinet. You probably would be happy to have a sticky bun a day to ward off colon cancer too.
Compound in cinnamon may provide resistance to colorectal cancer.
Researchers from the University of Arizona (UA) College of Pharmacy Department of Pharmacology and Toxicity and the UA Cancer Center believe that "a compound derived from cinnamon is a potent inhibitor of colorectal cancer," according to an article in Cancer Prevention Research and reported in Science Daily (http://www.sciencedaily.com/releases/2015/06/150615094439.htm).

Georg Wondrak, Ph.D., associate professor, and Donna Zhang, Ph.D., professor, who are affiliated with both institutions, have completed a study proving that the addition of cinnamaldehyde, the chemical compound that gives cinnamon its flavor and aroma, to the diet of mice protected the mice against colorectal cancer. When they were fed cinnamaldehyde, the "animals' cells had acquired the ability to protect themselves against exposure to a carcinogen through detoxification and repair," the article said.

According to Zhang, there is "an urgent need to develop more effective strategies" against colorectal cancer, which can be aggressive and difficult to control if not diagnosed early. Wondrak, who said that cinnamon is the third-most-consumed spice in the world, was eager to explore its health benefits, something that has not been done. Interestingly, colorectal cancer is the third-most-common cancer in the United States.

Colorectal cancer, or colon cancer, which occurs in the colon or rectum, when discovered early, is highly treatable, according to the Colorectal Cancer Alliance website, which adds. "Even if it spreads into nearby lymph nodes, surgical treatment followed by chemotherapy is highly successful. In the most difficult cases - when the cancer has metastasized to the liver, lungs or other sites - treatment can prolong and add to one's quality of life. Most colon cancers develop first as colorectal polyps, which are abnormal growths inside the colon or rectum that may later become cancerous." The American Cancer Society estimated that 136,830 people would be diagnosed in 2014 and 50,310 would succumb to colon cancer in the United States. Risk factors include being over 50, having polyps, having a family history of colon cancer and having genetic alterations (http://www.ccalliance.org/colorectal_cancer/overview.html).

The study, 'Nrf2-dependent suppression of azoxymethane/dextrane sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde,' has been published online. Now the researchers want to determine whether cinnamon, as differentiated from cinnamaldehyde, can prevent colorectal cancer as well as other diseases, such as inflammatory dysregulation and diabetes. Because cinnamon is considered safe, a human clinical trial could be relatively easy to obtain.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 30, 2018
Cancer
JUL 30, 2018
Challenges Coming to a Cancer Diagnosis in the UK
England's NHS Cancer Patient Experience Survey shows some cancers take longer for GPs to recognize....
AUG 07, 2018
Cancer
AUG 07, 2018
Renal Cell Carcinoma and Myelodysplastic Syndrome Show Epigenetic Association
DNA methylation patterns in renal cell carcinoma (RCC) have a strong association with myelodysplastic syndrome DNA hypermethylation later in life....
AUG 21, 2018
Cancer
AUG 21, 2018
Theranostics.....Heard of it?
Theranostics is an emerging field that combines therapeutics and diagnostic capabilities into one opportunity for treatment of diseases, especially cancer....
SEP 13, 2018
Cancer
SEP 13, 2018
Breast tumors can stop their own metastasis
According to the American cancer society, metastatic breast cancers or stage 4 breast cancers have 5-years survival rate of 22% which is lower than at early stages. Metastatic breast cancer...
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Re-sensitizing Drug-resistant Human Tumor Cells
Understanding how cancer cells avoid death despite their DNA being damaged will create new strategies to enhance cancer cell killing through chemotherapy t...
NOV 20, 2018
Cell & Molecular Biology
NOV 20, 2018
A Warning About Using Epigenetic Modifiers as Therapeutic Targets
In the long run, some cancer therapeutics may be doing more harm than good....
Loading Comments...